Milton Rodriguez on Success of The 2nd Excellence Stroke Training Center Plus in Peru
Milton Rodriguez, MSL and Medical Advisor at Boehringer Ingelheim, shared on LinkedIn:
”Thrilled to share the success of our second Excellence Stroke Training Center Plus (ESTC+ ) in Peru!
Over two intensive days, 45 emergency physicians and neurologists participated in advanced training focused on stroke and STEMI management, combining lectures, skill stations, and high-fidelity clinical simulations across prehospital and in-hospital scenarios.
This initiative, led by Boehringer Ingelheim, reinforces our commitment to continuing medical education (CME) and positions Peru at the forefront of innovative training in acute care in Stroke and STEMI.
Key highlights:
- Hands-on simulation to strengthen decision-making and teamwork under real-life conditions
- Collaboration with leading scientific societies and Universidad Científica del Sur
- Faculty composed of top experts in neurology, cardiology, and emergency medicine
A huge thank you to everyone who made this possible—our dedicated faculty, healthcare professionals, and the Boehringer Ingelheim team driving this vision forward.
Together, we are raising the standard of care for Stroke and STEMI patients in Latin America.
Let’s keep building excellence in healthcare education!”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?